Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.31 is in line with its 5-year average of 3.47, near the low end of its 5-year range (2.82–4.51).
As of the fiscal period ended Saturday, December 27, 2025. 4.09% above its 12-month average of 3.18.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
3.31
EARNINGS PER SHARE (EPS) AVG TTM
3.18
EARNINGS PER SHARE (EPS) AVG 3Y
3.37
EARNINGS PER SHARE (EPS) AVG 5Y
3.47
EARNINGS PER SHARE (EPS) AVG 10Y
3.31
EARNINGS PER SHARE (EPS) AVG 15Y
2.89
EARNINGS PER SHARE (EPS) AVG 20Y
2.58
CURRENT VS TTM AVG
+4.09%
CURRENT VS 3Y AVG
-1.85%
CURRENT VS 5Y AVG
-4.61%
CURRENT VS 10Y AVG
+0.00%
CURRENT VS 15Y AVG
+14.61%
CURRENT VS 20Y AVG
+28.25%
Henry Schein, Inc.
Market Cap
$10.04B
Earnings Per Share (EPS)
3.31
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$10.25B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.37B
Earnings Per Share (EPS)
-7.29
TTM Avg
-6.79
3Y Avg
-1.56
5Y Avg
-0.26
Market Cap
$10.51B
Earnings Per Share (EPS)
24.38
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$9.49B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$9.12B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
Market Cap
$11.32B
Earnings Per Share (EPS)
0.69
TTM Avg
0.77
3Y Avg
1.27
5Y Avg
1.25
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $10.04B | 3.31 | 3.18 | 3.37 | 3.47 |
| Molina Healthcare, Inc. (MOH)vs › | $10.25B | 0.19 | 14.72 | 15.46 | 14.11 |
| Insulet Corp. (PODD)vs › | $9.78B | 5.35 | 4.74 | 3.13 | 2.14 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.29 | -6.79 | -1.56 | -0.26 |
| Universal Health Services, Inc. (UHS)vs › | $10.51B | 24.38 | 20.29 | 15.04 | 13.87 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 8.25 | -18.74 | -45.28 | 14.90 |
| Tempus AI, Inc. (TEM)vs › | $9.12B | -1.44 | -3.00 | -2.43 | -2.16 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 0.69 | 0.77 | 1.27 | 1.25 |
| DaVita Inc. (DVA)vs › | $11.80B | 11.21 | 10.37 | 8.56 | 8.35 |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 5.76 | 5.64 | 5.43 | 9.01 |
Trailing EPS (TTM)
$3.31
Forward EPS (Est.)
$5.38
P/E Ratio
26.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-27 | 3.29 |
| 2024-12-28 | 3.07 |
| 2023-12-31 | 3.18 |
| 2022-12-31 | 3.95 |
| 2021-12-31 | 4.51 |
| 2020-12-31 | 2.82 |
| 2019-12-31 | 3.44 |
| 2018-12-31 | 3.51 |
| 2017-12-31 | 2.59 |
| 2016-12-31 | 3.16 |
| 2015-12-31 | 2.89 |
| 2014-12-31 | 2.77 |
| 2013-12-31 | 2.58 |
| 2012-12-31 | 2.22 |
| 2011-12-31 | 2.04 |
| 2010-12-31 | 1.81 |
| 2009-12-31 | 1.74 |
| 2008-12-31 | 1.39 |
| 2007-12-31 | 1.33 |
| 2006-12-31 | 1.04 |
| 2005-12-31 | 0.87 |
| 2004-12-31 | 0.74 |
| 2003-12-31 | 0.79 |
| 2002-12-31 | 0.67 |
| 2001-12-31 | 0.26 |
| 2000-12-31 | 0.17 |
| 1999-12-31 | 0.04 |
| 1998-12-31 | 0.01 |
| 1997-12-31 | 0.00 |
| 1996-12-31 | 0.02 |
Reported annual fiscal-period values; no daily interpolation.
